Literature DB >> 8653681

Multiple head and neck tumors: evidence for a common clonal origin.

G C Bedi1, W H Westra, E Gabrielson, W Koch, D Sidransky.   

Abstract

Patients with head and neck cancers have a high (2-3%/year) incidence of second primary lesions. Clinically, these new lesions are identified either simultaneously with the primary lesion (synchronous) or after a period of time (metachronous). This observation has been attributed to the concept of "field carcinogenesis," which is based on the hypothesis that prolonged exposure to carcinogens leads to the independent transformation of multiple epithelial cells at several sites. An alternative theory is based on the premise that any transforming event is rare; following initial transformation, the progeny of the transformed clone spread through the mucosa and give rise to geographically distinct but genetically related tumors. We analyzed the pattern of X-chromosome inactivation in multiple primary tumors from eight female patients with head and neck cancer. In addition, we used microsatellite analysis to examine the pattern of allelic loss on chromosomes 9p and 3p, identified as early events in the progression of head and neck malignancies. In four of four cases, multiple tumors demonstrated the same pattern of X-chromosome inactivation. In the remaining four cases, X-chromosome deletions prevented interpretation (n = 3), or the androgen receptor locus was noninformative (n = 1). In three of nine patients, multiple tumors displayed the same pattern of loss of heterozygosity, two with identical breakpoints on chromosome 9p. In one patient, there was an identical microsatellite alteration at a 3p locus, definitive evidence that these tumors arose from the same clone. Our findings suggest that in at least a proportion of patients with head and neck cancers, multiple primary tumors arise from a single clone.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8653681

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  52 in total

Review 1.  The clonal origin and clonal evolution of epithelial tumours.

Authors:  S B Garcia; M Novelli; N A Wright
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

2.  Coculturing diverse clonal populations prevents the early-stage neoplastic progression that occurs in the separate clones.

Authors:  M Chow; H Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

3.  Clonal dynamics of progressive neoplastic transformation.

Authors:  M Chow; H Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

4.  The cellular ecology of progressive neoplastic transformation: a clonal analysis.

Authors:  M Chow; H Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

5.  Recurrent chromosomal imbalances detected in biopsy material from oral premalignant and malignant lesions by combined tissue microdissection, universal DNA amplification, and comparative genomic hybridization.

Authors:  R G Weber; M Scheer; I A Born; S Joos; J M Cobbers; C Hofele; G Reifenberger; J E Zöller; P Lichter
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

Review 6.  Open questions and novel concepts in oral cancer surgery.

Authors:  Giancarlo Tirelli; Serena Zacchigna; Matteo Biasotto; Marco Piovesana
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-05-24       Impact factor: 2.503

7.  Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis.

Authors:  T Yamada; A T De Souza; S Finkelstein; R L Jirtle
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

8.  Molecular characterization of late stomal recurrence following total laryngectomy.

Authors:  Josena K Stephen; Mausumi Symal; Kang Mei Chen; Tamer Ghanem; Robert Deeb; Veena Shah; Shaleta Havard; Maria J Worsham
Journal:  Oncol Rep       Date:  2011-01-10       Impact factor: 3.906

9.  An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasia.

Authors:  Charles M Rudin; Ezra E W Cohen; Vassiliki A Papadimitrakopoulou; Sol Silverman; Wendy Recant; Adel K El-Naggar; Kirsten Stenson; Scott M Lippman; Waun Ki Hong; Everett E Vokes
Journal:  J Clin Oncol       Date:  2003-11-03       Impact factor: 44.544

10.  Oral hybrid verrucous carcinoma: a clinical study.

Authors:  Sandhya Gokavarapu; L M Chandrasekhara Rao S; Uma Sankar Tantravahi; Sandhya Devi Gundimeda; T Subramaneshwar Rao; Sudha Murthy
Journal:  Indian J Surg Oncol       Date:  2014-08-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.